List of Excipients in API TENOFOVIR DISOPROXIL FUMARATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TENOFOVIR DISOPROXIL FUMARATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | ALUMINUM OXIDE | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | CELLULOSE, MICROCRYSTALLINE | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | CROSCARMELLOSE SODIUM | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | FD&C BLUE NO. 2 | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | HYPROMELLOSE 2910 | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | LACTOSE MONOHYDRATE | |
| A-S Medication Solutions | VIREAD | tenofovir disoproxil fumarate | 50090-0754 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing TENOFOVIR DISOPROXIL FUMARATE
Detailed excipient profiles for TENOFOVIR DISOPROXIL FUMARATE
Excipient focus: ALUMINUM OXIDE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | tenofovir disoproxil fumarate | 50090-0754 |
| Avera McKennan Hospital | tenofovir disoproxil fumarate | 69189-0401 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM STEARATE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing CELLULOSE, MICROCRYSTALLINE
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
TENOFOVIR DISOPROXIL FUMARATE drug variants containing CROSCARMELLOSE SODIUM
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
TENOFOVIR DISOPROXIL FUMARATE drug variants containing FD&C BLUE NO. 2
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: HYPROMELLOSE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | tenofovir disoproxil fumarate | 50090-7202 |
| Bryant Ranch Prepack | tenofovir disoproxil fumarate | 63629-9729 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
TENOFOVIR DISOPROXIL FUMARATE drug variants containing HYPROMELLOSE 2910
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
TENOFOVIR DISOPROXIL FUMARATE drug variants containing HYPROMELLOSES
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing LACTOSE MONOHYDRATE
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing MAGNESIUM STEARATE
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
TENOFOVIR DISOPROXIL FUMARATE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | tenofovir disoproxil fumarate | 50268-758 |
| DOH CENTRAL PHARMACY | tenofovir disoproxil fumarate | 53808-1128 |
| Strides Pharma Science Limited | tenofovir disoproxil fumarate | 64380-714 |
| REMEDYREPACK INC | tenofovir disoproxil fumarate | 70518-1002 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
TENOFOVIR DISOPROXIL FUMARATE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
TENOFOVIR DISOPROXIL FUMARATE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | tenofovir disoproxil fumarate | 69097-533 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
TENOFOVIR DISOPROXIL FUMARATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
TENOFOVIR DISOPROXIL FUMARATE drug variants containing STARCH, CORN
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
TENOFOVIR DISOPROXIL FUMARATE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tenofovir disoproxil fumarate tablets | 62135-466 |
| >Company | >Ingredient | >NDC |
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
TENOFOVIR DISOPROXIL FUMARATE drug variants containing TITANIUM DIOXIDE
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
TENOFOVIR DISOPROXIL FUMARATE drug variants containing TRIACETIN
TENOFOVIR DISOPROXIL FUMARATE drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
